Taiwan consensus statement on the management of chronic hepatitis B-Reference-Cited by-同舟云学术

Taiwan consensus statement on the management of chronic hepatitis B

Published:2019-01 Issue:1 Volume:118 Page:7-38
ISSN:0929-6646
Container-title:Journal of the Formosan Medical Association
language:en
Short-container-title:Journal of the Formosan Medical Association

Author:

Chien Rong-Nan,Kao Jia-Horng,Peng Cheng-Yuan,Chen Chien-Hung,Liu Chun-Jen,Huang Yi-Hsiang^ORCID,Hu Tsung-Hui,Yang Hwa-I,Lu Sheng-Nan,Ni Yen-Hsuan,Chuang Won-Long,Lee Chuan-Mo,Wu Jaw-Chin,Chen Pei-Jer,Liaw Yun-Fan^ORCID

Funder

Taiwan Association for the Study of Liver

Ministry of Science and Technology

Publisher

Elsevier BV

Subject

General Medicine

Reference312 articles.

1. Hepatitis B virus infection;Liaw;Lancet,2009

2. Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels;Chu;Am J Med,2004

3. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors;Fattovich;J Hepatol,2008

4. Understanding the immunopathogenesis of chronic hepatitis B: an Asian prospective;Tan;J Gastroenterol Hepatol,2008

5. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level;Chen;JAMA,2006

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unmet needs in the clinical management of chronic hepatitis B infection;Journal of the Formosan Medical Association;2024-08

2. A non-invasive diagnostic nomogram for CHB-related early cirrhosis: a prospective study;Scientific Reports;2024-07-03

3. Sex and ethnic disparities in hepatitis B evaluation and treatment across the world;Journal of Hepatology;2024-07

4. Phase 1b/2a randomized study of heterologous ChAdOx1-HBV/MVA-HBV therapeutic vaccination (VTP-300) as monotherapy and combined with low-dose nivolumab in virally-suppressed patients with chronic hepatitis B;Journal of Hepatology;2024-07

5. Entecavir vs. tenofovir disoproxil fumarate in the treatment of chronic hepatitis B patients with severe acute exacerbation;European Journal of Gastroenterology & Hepatology;2024-06-26